On the public citation graph

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

https://doi.org/10.1371/journal.pmed.1003149
0 signed · 158 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.28431openalex-snapshot
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
inferredcites →https://doi.org/10.1002/hep.29465openalex-snapshot
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
inferredcites →https://doi.org/10.1002/hep.30254openalex-snapshot
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States
inferredcites →https://doi.org/10.1007/978-1-4614-7209-4_8openalex-snapshot
Highly Multiplexed Antibody Suspension Bead Arrays for Plasma Protein Profiling
inferredcites →https://doi.org/10.1007/s00125-014-3216-xopenalex-snapshot
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium
inferredcites →https://doi.org/10.1007/s00125-019-4906-1openalex-snapshot
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium
inferredcites →https://doi.org/10.1016/j.cld.2007.02.003openalex-snapshot
The Role of Genomics and Proteomics: Technologies in Studying Non-alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.dld.2009.08.002openalex-snapshot
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.dsx.2016.12.033openalex-snapshot
Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.jhep.2015.11.008openalex-snapshot
FibroGENE: A gene-based model for staging liver fibrosis
inferredcites →https://doi.org/10.1016/j.jhep.2016.05.013openalex-snapshot
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
inferredcites →https://doi.org/10.1016/j.jhep.2017.09.003openalex-snapshot
Genetics and epigenetics of NAFLD and NASH: Clinical impact
inferredcites →https://doi.org/10.1016/j.jhep.2018.10.033openalex-snapshot
Non-alcoholic fatty liver disease – A global public health perspective
inferredcites →https://doi.org/10.1016/j.metabol.2016.01.012openalex-snapshot
Epidemiology and natural history of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.metabol.2019.154005openalex-snapshot
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
inferredcites →https://doi.org/10.1016/j.metabol.2019.154010openalex-snapshot
Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?
inferredcites →https://doi.org/10.1016/j.pnmrs.2013.04.001openalex-snapshot
Whole body fat: Content and distribution
inferredcites →https://doi.org/10.1016/j.tem.2008.08.005openalex-snapshot
Insulin resistance, inflammation, and non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/s0140-6736(05)67402-8openalex-snapshot
The metabolic syndrome—a new worldwide definition
inferredcites →https://doi.org/10.1016/s0140-6736(17)33102-1openalex-snapshot
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
inferredcites →https://doi.org/10.1038/ejcn.2017.43openalex-snapshot
Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample
inferredcites →https://doi.org/10.1038/srep24740openalex-snapshot
Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD
inferredcites →https://doi.org/10.1038/srep43238openalex-snapshot
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
inferredcites →https://doi.org/10.1053/j.gastro.2009.06.005openalex-snapshot
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
inferredcites →https://doi.org/10.1053/j.gastro.2017.01.015openalex-snapshot
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1053/j.gastro.2018.12.036openalex-snapshot
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1080/00031305.1992.10475879openalex-snapshot
An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression
inferredcites →https://doi.org/10.1080/00365521.2017.1379556openalex-snapshot
IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD – a pilot study
inferredcites →https://doi.org/10.1093/bioinformatics/btw079openalex-snapshot
RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data
inferredcites →https://doi.org/10.1111/aji.12512openalex-snapshot
Simple Plex™: A Novel Multi‐Analyte, Automated Microfluidic Immunoassay Platform for the Detection of Human and Mouse Cytokines and Chemokines
inferredcites →https://doi.org/10.1111/apt.12963openalex-snapshot
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.2517-6161.1996.tb02080.xopenalex-snapshot
Regression Shrinkage and Selection Via the Lasso
inferredcites →https://doi.org/10.1111/liv.13299openalex-snapshot
The epidemiology of non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/liv.13643openalex-snapshot
Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future
inferredcites →https://doi.org/10.1111/liv.13658openalex-snapshot
Diagnosis of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: Non‐invasive tests are enough
inferredcites →https://doi.org/10.1126/science.1260419openalex-snapshot
Tissue-based map of the human proteome
inferredcites →https://doi.org/10.1126/scisignal.aaz0274openalex-snapshot
The human secretome
inferredcites →https://doi.org/10.1136/bmj.g4596openalex-snapshot
Non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1186/1471-2105-8-25openalex-snapshot
Bias in random forest variable importance measures: Illustrations, sources and a solution
inferredcites →https://doi.org/10.1186/1471-230x-6-33openalex-snapshot
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
inferredcites →https://doi.org/10.1186/1476-5926-4-10openalex-snapshot
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
inferredcites →https://doi.org/10.1186/1746-6148-10-122openalex-snapshot
Metabolomic biomarkers correlating with hepatic lipidosis in dairy cows
inferredcites →https://doi.org/10.1186/s12916-014-0123-4openalex-snapshot
Type 2 diabetes as a disease of ectopic fat?
inferredcites →https://doi.org/10.1186/s13040-017-0142-8openalex-snapshot
EFS: an ensemble feature selection tool implemented as R-package and web-application
inferredcites →https://doi.org/10.1371/journal.pmed.1001779openalex-snapshot
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
inferredcites →https://doi.org/10.1371/journal.pone.0095192openalex-snapshot
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
inferredcites →https://doi.org/10.1371/journal.pone.0172921openalex-snapshot
Characterisation of liver fat in the UK Biobank cohort
inferredcites →https://doi.org/10.1371/journal.pone.0214436openalex-snapshot
Non-invasive assessment of NAFLD as systemic disease—A machine learning perspective
inferredcites →https://doi.org/10.18637/jss.v033.i01openalex-snapshot
Regularization Paths for Generalized Linear Models via Coordinate Descent
inferredcites →https://doi.org/10.2147/jep.s150729openalex-snapshot
Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis
inferredcites →https://doi.org/10.2337/diacare.22.9.1462openalex-snapshot
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.
inferredcites →https://doi.org/10.2337/diacare.23.3.295openalex-snapshot
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
inferredcites →https://doi.org/10.2337/diacare.24.3.539openalex-snapshot
A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test
inferredcites →https://doi.org/10.32614/r.manualsopenalex-snapshot
R: A Language and Environment for Statistical Computing
inferredcites →https://doi.org/10.3390/ijms18010021openalex-snapshot
Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis
inferredcites →https://doi.org/10.3390/ijms19051308openalex-snapshot
Insulin-Like Growth Factor (IGF) System in Liver Diseases
inferredcites →https://doi.org/10.3748/wjg.v22.i10.3023openalex-snapshot
Fatty liver indexvswaist circumference for predicting non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.4103/0019-5154.190118openalex-snapshot
Methodology series module 5: Sampling strategies
inferredcites →https://doi.org/10.5114/ceh.2018.78120openalex-snapshot
A systematic review of the present and future of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.7555/jbr.32.20180045openalex-snapshot
Non-alcoholic fatty liver disease: a narrative review of genetics

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3925473openalex-extracted
The Report on China-Spain Joint Clinical Testing for Rapid COVID-19 Risk Screening by Eye-Region Manifestations
inferred← citeshttps://doi.org/10.2139/ssrn.4481966openalex-extracted
Artificial Intelligence in Identifying Patients with Undiagnosed Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1002/dmrr.70129openalex-snapshot
Recent Advances in the Application of Machine Learning Models in Metabolic Dysfunction–Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.1002/hep.31869openalex-snapshot
Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art
inferred← citeshttps://doi.org/10.1002/ird3.24openalex-snapshot
Radiobioinformatics: A novel bridge between basic research and clinical practice for clinical decision support in diffuse liver diseases
inferred← citeshttps://doi.org/10.1002/jum.16194openalex-snapshot
Ultrasound‐Based Machine Learning Approach for Detection of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/smmd.20220029openalex-snapshot
Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
inferred← citeshttps://doi.org/10.1007/978-3-030-60884-2_18openalex-snapshot
Fatty Chain Acids Risk Factors in Sudden Infant Death Syndrome: A Genetic Algorithm Approach
inferred← citeshttps://doi.org/10.1007/s00535-022-01932-1openalex-snapshot
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum
inferred← citeshttps://doi.org/10.1007/s10863-025-10078-7openalex-snapshot
Integrated analysis of RNA-binding proteins in MAFLD: mechanistic insights and diagnostic biomarker potential via alternative splicing
inferred← citeshttps://doi.org/10.1007/s11596-026-00190-zopenalex-snapshot
Targeting the Gut-Liver Mitochondria Axis in MASLD: Mechanisms and Therapeutic Perspectives
inferred← citeshttps://doi.org/10.1007/s43657-023-00128-8openalex-snapshot
Phenomic Imaging
inferred← citeshttps://doi.org/10.1016/b978-0-443-19116-9.00043-9openalex-snapshot
Multiomics biomarkers of health and disease
inferred← citeshttps://doi.org/10.1016/b978-0-443-21870-5.00032-7openalex-snapshot
Prediction of nonalcoholic fatty liver disease using machine learning
inferred← citeshttps://doi.org/10.1016/j.ajcnut.2024.01.007openalex-snapshot
Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions – a narrative review
inferred← citeshttps://doi.org/10.1016/j.archger.2024.105497openalex-snapshot
A commentary on “Causal relationship between gut microbiota and obstructive sleep apnea”
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112298openalex-snapshot
Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
inferred← citeshttps://doi.org/10.1016/j.cgh.2023.04.007openalex-snapshot
Artificial Intelligence Applications in Hepatology
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2025.109661openalex-snapshot
Integrating genetics, metabolites, and clinical characteristics in predicting cardiometabolic health outcomes using machine learning algorithms – A systematic review
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2026.111619openalex-snapshot
Artificial intelligence for metabolic dysfunction-associated steatotic liver disease diagnosis: A systematic review
inferred← citeshttps://doi.org/10.1016/j.csbj.2021.05.024openalex-snapshot
Machine learning applied to serum and cerebrospinal fluid metabolomes revealed altered arginine metabolism in neonatal sepsis with meningoencephalitis
inferred← citeshttps://doi.org/10.1016/j.dld.2021.06.011openalex-snapshot
The application of artificial intelligence in hepatology: A systematic review
inferred← citeshttps://doi.org/10.1016/j.ebiom.2020.103147openalex-snapshot
Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.eclinm.2026.103921openalex-snapshot
Prediction of trajectories and outcomes in early-stage metabolic dysfunction-associated steatotic liver disease: a narrative review
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.178183openalex-snapshot
Harnessing AI for precision medicine and its applications in genomics, systems pharmacology, and drug discovery
inferred← citeshttps://doi.org/10.1016/j.hbpd.2021.08.004openalex-snapshot
Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study
inferred← citeshttps://doi.org/10.1016/j.jceh.2025.102611openalex-snapshot
The Integration of Multi-omics With Artificial Intelligence in Hepatology: A Comprehensive Review of Personalized Medicine, Biomarker Identification, and Drug Discovery
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.03.035openalex-snapshot
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
inferred← citeshttps://doi.org/10.1016/j.jhepr.2024.101185openalex-snapshot
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
inferred← citeshttps://doi.org/10.1016/j.metabol.2026.156552openalex-snapshot
A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis
inferred← citeshttps://doi.org/10.1016/j.ncrna.2024.10.002openalex-snapshot
Innovative approaches to metabolic dysfunction-associated steatohepatitis diagnosis and stratification
inferred← citeshttps://doi.org/10.1016/j.phrs.2025.107647openalex-snapshot
The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.transci.2024.104028openalex-snapshot
Mechanistic insights from a pilot exploratory study of the dynamic proteomic changes during plasma exchange in patients with acute liver failure
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2026.03.006openalex-snapshot
A Two-Step Approach Combining Steatosis Biomarkers and Multiparametric Quantitative US Enhances Noninvasive Diagnosis of Hepatic Steatosis
inferred← citeshttps://doi.org/10.1016/s2213-8587(23)00165-1openalex-snapshot
Precision medicine for cardiometabolic disease: a framework for clinical translation
inferred← citeshttps://doi.org/10.1038/s41467-025-62985-3openalex-snapshot
Advances in artificial intelligence and precision nutrition approaches to improve maternal and child health in low resource settings
inferred← citeshttps://doi.org/10.1038/s41467-026-70308-3openalex-snapshot
Associations of continuous glucose monitor derived time in range and glycaemic variability with diet lifestyle and demographics
inferred← citeshttps://doi.org/10.1038/s41574-023-00898-1openalex-snapshot
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1038/s41591-020-01183-8openalex-snapshot
Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
inferred← citeshttps://doi.org/10.1038/s41591-022-01850-yopenalex-snapshot
Noninvasive proteomic biomarkers for alcohol-related liver disease
inferred← citeshttps://doi.org/10.1038/s41598-022-15364-7openalex-snapshot
Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells
inferred← citeshttps://doi.org/10.1038/s41598-025-17386-3openalex-snapshot
Diagnostic accuracy of artificial intelligence models for imaging detection of hepatic steatosis through systematic review and meta analysis
inferred← citeshttps://doi.org/10.1038/s41598-025-96478-6openalex-snapshot
Predicting metabolic dysfunction associated steatotic liver disease using explainable machine learning methods
inferred← citeshttps://doi.org/10.1038/s41598-026-36834-2openalex-snapshot
Diagnosis and grading of steatotic liver disease via clinical and laboratory data using machine learning
inferred← citeshttps://doi.org/10.1063/5.0133327openalex-snapshot
A descriptive study of fatty liver disease detection using machine learning
inferred← citeshttps://doi.org/10.1088/1757-899x/1022/1/012029openalex-snapshot
Machine Learning in liver disease diagnosis: Current progress and future opportunities
inferred← citeshttps://doi.org/10.1093/ajcn/nqab392openalex-snapshot
Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study
inferred← citeshttps://doi.org/10.1093/jamia/ocab003openalex-snapshot
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1093/stcltm/szaf066openalex-snapshot
Predicting metabolic dysfunction–associated steatotic liver disease risk using patient-derived induced pluripotent stem cells
inferred← citeshttps://doi.org/10.1097/meg.0000000000002451openalex-snapshot
Risk prediction model for early postoperative death in patients with hepatocellular carcinoma: a retrospective study based on random forest algorithm and logistic regression
inferred← citeshttps://doi.org/10.1101/2021.08.31.21262709openalex-snapshot
Inferring causal pathways between metabolic processes and liver fat accumulation: an IMI DIRECT study
inferred← citeshttps://doi.org/10.1101/2021.09.24.21263766openalex-snapshot
The Report on China-Spain Joint Clinical Testing for Rapid COVID-19 Risk Screening by Eye-region Manifestations
inferred← citeshttps://doi.org/10.1101/2022.02.07.22270652openalex-snapshot
Marker genes of incident type 1 diabetes in peripheral blood mononuclear cells of children: A machine learning strategy for large-p, small-n scenarios
inferred← citeshttps://doi.org/10.1101/2025.01.14.632908openalex-snapshot
Decoding MASLD Progression: A Molecular Trajectory-Based Framework for Modelling Disease Dynamics
inferred← citeshttps://doi.org/10.1101/2025.06.02.25328773openalex-snapshot
A Biological-Systems-Based Analyses Using Proteomic and Metabolic Network Inference Reveals Mechanistic Insights into Hepatic Lipid Accumulation: An IMI-DIRECT Study
inferred← citeshttps://doi.org/10.1109/iciteics61368.2024.10625550openalex-snapshot
Prediction of Chronic Liver Disease Using Machine Learning Algorithms and Interpretation with SHAP Kernels
inferred← citeshttps://doi.org/10.1109/icnpcv69434.2026.11708912openalex-snapshot
FattyLiverClassifier: A Texture Aware Deep Learning Framework for Ultrasound Segmentation and Severity Grading of Fatty Lever Disease
inferred← citeshttps://doi.org/10.1111/dom.16348openalex-snapshot
Comparative efficacy and safety of pharmacologic therapies for metabolic dysfunction‐associated steatotic liver disease over 24 weeks in reducing liver steatosis and fibrosis: A network meta‐analysis
inferred← citeshttps://doi.org/10.1111/dom.70824openalex-snapshot
Large‐Scale Plasma Proteomics Improves Prediction of Major Adverse Liver Outcomes in Individuals With MASLD
inferred← citeshttps://doi.org/10.1111/hiv.13060openalex-snapshot
Diagnostic value of serological biomarkers for detection of non‐alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
inferred← citeshttps://doi.org/10.1111/ijpo.12947openalex-snapshot
Possible prediction of obesity‐related liver disease in children and adolescents using indices of body composition
inferred← citeshttps://doi.org/10.1111/jvim.16580openalex-snapshot
Demographic and histopathologic features of dogs with abnormally high concentrations of hepatic copper
inferred← citeshttps://doi.org/10.1136/bmjhci-2021-100510openalex-snapshot
Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH)
inferred← citeshttps://doi.org/10.1136/gutjnl-2023-331740openalex-snapshot
Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment
inferred← citeshttps://doi.org/10.1145/3506651.3506658openalex-snapshot
CoFIM: A Computational Framework for Proteomic and Metabolomic Integrated Data Analysis
inferred← citeshttps://doi.org/10.1155/2022/9635526openalex-snapshot
Machine Learning-Based Prediction Model of Preterm Birth Using Electronic Health Record
inferred← citeshttps://doi.org/10.1172/jci189953openalex-snapshot
Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD
inferred← citeshttps://doi.org/10.1177/17562848211062807openalex-snapshot
Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s12880-021-00610-7openalex-snapshot
Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ
inferred← citeshttps://doi.org/10.1186/s12880-026-02563-1openalex-snapshot
Construction of a prognostic model for colorectal cancer based on clinical parameters and quantitative body composition using CT imaging
inferred← citeshttps://doi.org/10.1186/s40249-025-01291-yopenalex-snapshot
Gut microbiota metabolites impact immunologic responses to antiretroviral therapy in HIV-infected men who have sex with men
inferred← citeshttps://doi.org/10.1186/s43066-022-00224-wopenalex-snapshot
Artificial intelligence in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1210/clinem/dgab098openalex-snapshot
Fasting Plasma GLP-1 Is Associated With Overweight/Obesity and Cardiometabolic Risk Factors in Children and Adolescents
inferred← citeshttps://doi.org/10.1210/clinem/dgac108openalex-snapshot
Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia
inferred← citeshttps://doi.org/10.12785/ijcds/110183openalex-snapshot
Intelligent Identification of Liver Diseases Based on Incremental Hidden Layer Neurons ANN Model
inferred← citeshttps://doi.org/10.1371/journal.pone.0299487openalex-snapshot
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information
inferred← citeshttps://doi.org/10.14218/jcth.2020.00132openalex-snapshot
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.14569/ijacsa.2024.0150273openalex-snapshot
Employing a Hybrid Convolutional Neural Network and Extreme Learning Machine for Precision Liver Disease Forecasting
inferred← citeshttps://doi.org/10.1530/ec-24-0470openalex-snapshot
Identification of tryptophan metabolism-related biomarkers for nonalcoholic fatty liver disease through network analysis
inferred← citeshttps://doi.org/10.2196/59810openalex-snapshot
Determinants of Visual Impairment Among Chinese Middle-Aged and Older Adults: Risk Prediction Model Using Machine Learning Algorithms
inferred← citeshttps://doi.org/10.2196/preprints.44424openalex-snapshot
Identification of risk indicators for periodontitis: Machine Learning and Feature Importance Analysis (Preprint)
inferred← citeshttps://doi.org/10.2196/preprints.59810openalex-snapshot
Prediction and Determinants of Visual Impairment among Chinese Middle-aged and Elderly Adults: Machine Learning Algorithms (Preprint)
inferred← citeshttps://doi.org/10.2196/preprints.63621openalex-snapshot
Predicting risk indicators for periodontitis in a Korean population: Machine learning algorithms approach (Preprint)
inferred← citeshttps://doi.org/10.29007/6x7wopenalex-snapshot
Detecting Non-Alcoholic Fatty Liver Disease (NAFLD) using Clinical Reports
inferred← citeshttps://doi.org/10.31579/2834-8788/014openalex-snapshot
Leveraging AutoML to provide NAFLD screening diagnosis: Proposed machine learning models
inferred← citeshttps://doi.org/10.3389/fendo.2024.1450317openalex-snapshot
Advancing non-alcoholic fatty liver disease prediction: a comprehensive machine learning approach integrating SHAP interpretability and multi-cohort validation
inferred← citeshttps://doi.org/10.3389/fonc.2026.1803957openalex-snapshot
Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review
inferred← citeshttps://doi.org/10.3389/frai.2022.1050439openalex-snapshot
Artificial intelligence applied to omics data in liver diseases: Enhancing clinical predictions
inferred← citeshttps://doi.org/10.3390/ijms25115965openalex-snapshot
Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach
inferred← citeshttps://doi.org/10.3390/jcm10204673openalex-snapshot
Defining NASH from a Multi-Omics Systems Biology Perspective
inferred← citeshttps://doi.org/10.3390/nu14194180openalex-snapshot
Ethanol Extract of Licorice Alleviates HFD-Induced Liver Fat Accumulation in Association with Modulation of Gut Microbiota and Intestinal Metabolites in Obesity Mice
inferred← citeshttps://doi.org/10.35712/aig.v3.i2.46openalex-snapshot
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
inferred← citeshttps://doi.org/10.36469/001c.123645openalex-snapshot
Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.36469/jheor.2024.123645openalex-snapshot
Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.4254/wjh.v17.i3.101721openalex-snapshot
Global trends in artificial intelligence applications in liver disease over seventeen years
inferred← citeshttps://doi.org/10.48550/arxiv.2109.08807openalex-snapshot
The Report on China-Spain Joint Clinical Testing for Rapid COVID-19 Risk Screening by Eye-region Manifestations
inferred← citeshttps://doi.org/10.6084/m9.figshare.14609062openalex-snapshot
Additional file 1 of Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ
inferred← citeshttps://doi.org/10.6084/m9.figshare.14609065openalex-snapshot
Additional file 2 of Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.